Astellas

Pharma

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

China approved the world's first commercial brain-computer interface. AZ expands cell therapy capabilities in China. Astellas ended a bispecific deal.

Angus Liu Mar 20, 2026 8:00am

Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia

Mar 13, 2026 8:05am

Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia

Mar 6, 2026 9:35am

Padcev-Keytruda combo wins in MIBC amid evolving landscape

Feb 27, 2026 10:00am

China deal growth, Daiichi CMO, Astellas-Vir—Fierce Pharma Asia

Feb 27, 2026 9:50am

Gilead, Tokyo IPO, China's GLP-1 market—Fierce Pharma Asia

Feb 20, 2026 11:12am